Clinical Trial Programme

​​​The primary objective of the Haematology clinical trials (research) programme is to improve the standards of care offered to our patients by participating in well designed clinical trials which can offer access to innovative treatments and drugs not normally available within New Zealand.

​The Haematologists are responsible for clinical research within their area of expertise and are supported by two Senior Research Coordinators, an Ethics Coordinator and a Research Assistant.  The clinical research team have a wide range of experience in trial work, including phase II and III studies, FDA registration studies, complying with ICH-GCP guidelines, data management, drug administration, patient education and quality assurance.

Professional Associations include the following local and international groups: 

  • ​​New Zealand Leukaemia Study Group (NZLSG) 
  • New Zealand Bone Marrow transplant Study Group (NZBMTSG)
  • Haematology Society of Australia and New Zealand (HSANZ) 
  • The Australasian Society of Thrombosis and Haemostasis (ASTH)
  • New Zealand Cancer and Blood Research Coordinators Group
  • Australasian Leukaemia and Lymphoma Group (ALLG) 
  • European Bone Marrow Transplant Group
  • American Society of Haematology
  • European Haematology Association
  • ​National Cancer Research Institute (NCRI)
rounded corners top

Related Documents

rounded corners bottom
Page last reviewed: 12 September 2013